Houston Methodist Hospital — Houston, Texas

Public research footprint of Houston Methodist Hospital, compiled from the ClinicalTrials.gov public registry.

644

Registered studies

305

Active

148

Recruiting now

236

Completed

Stopped or withdrawn

Most-studied conditions

Acute Respiratory Distress Syndrome (ARDS) · Endometrial Dedifferentiated Carcinoma · Recurrent Ovarian Carcinoma · Stage IB Lung Non-Small Cell Carcinoma AJCC v7

Recently updated registry entries

NCT00114101 — Lenalidomide in Treating Patients With Multiple Myeloma Undergoing Autologous Stem Cell… (Active Not Recruiting)
NCT05702034 — A Study of Milvexian in Participants After an Acute Ischemic Stroke or High-Risk… (Active Not Recruiting)
NCT01272037 — Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Houston Methodist Hospital?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.